|

Speculating on The Future of MindMed [Big News for MMED/MMEDF STOCK]

Hello back Psychedelic Investors! In this video we are going to be entering the Speculation Zone to discuss the implications of several of MindMed’s most recent moves. Aka, we shall be Speculating on The Future of MindMed [Big News for MMED/MMEDF STOCK].

Timestamps:
0:00 – Intro
2:52 – Speculating on LSD Trials
7:44 – MindMed’s Partnership Meaning
13:45 – Nasdaq Uplisting

This is actually the second video being released today. Earlier we posted a video detailing the three most recent press releases distributed by MindMed, where we explained what each move meant. If you haven’t seen that episode yet and want to get a detailed explanation of each Press Release before watching this video speculating on that information, you should probably do that first!

Well actually, MindMed has since released another press release since the first video was filmed, on the commencement of their LSD Neutraliser phase 1 clinical trial.
In our Video on MindMed’s Latest News, we discussed:

1. How MindMed has started a phase 1 clinical trial studying the effects of mixing LSD and MDMA;
2. We examined MindMed’s changes in Leadership, where JR Rahn became the sole CEO, and a gentleman by the name of Dr. Glick left the board;
3. We also talked about MindMed’s new partnership with a company called MindShift Compounds AG, which is developing novel compounds owned exclusively by MMED.

In this video, we discuss/SPECULATE on all of MindMed’s latest changes and how some of them could potentially influence the MMED/MMEDF stock’s uplisting on NASDAQ.

I hope you guys found some value in this and I’ll keep you posted for more changes!

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
Video by Pressmaster from Pexels

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

#MindMed #MMEDF #MindmedStock

Similar Posts

  • Stanley Cup Champion Discusses Healing Traumatic Brain Injury with Psychedelics | Wesana Health

    In today’s episode, we discuss healing traumatic brain injury, also know as (TBI) with two times Stanley Cup Champion Daniel Carcillo, Founder and CEO of Wesana Health (CNSX: WESA | OTC: WSNAF)

    For More Information on Wesana Health, visit:
    https://www.wesanahealth.com/

    Follow Wesana on Social Media:
    Twitter: @wesanahealth
    Instagram: @wesanahealth
    Facebook: @wesanahealth

    Follow us on Twitter:
    @Psy_Invest
    @psy_holy
    @PsycSpotlight
    Follow us on Instagram:
    @thepsychedelicinvestor
    @psycspotlight

    To learn more about the emerging psychedelic industry, visit:
    https://psychedelicspotlight.com/

    This video was conducted on behalf of Wesana Health, and was funded by Gold Standard Media LLC and/or affiliates. For our full disclaimer, please visit: https://portal.goldstandardir.com/disclaimer/WSNAF-85

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #WesanaHealth #WESASttock #Psychedelicstocks

  • Dr. Matthew Johnson discusses Psychedelics, the Hard Problem of Consciousness and UFOs

    During our time in Wonderland Miami, we had the pleasure to meet and interview Dr. Matthew Johnson of Johns Hopkins University. In this Psychedelic Spotlight Interview, we discuss a wide range of topics surrounding psychedelics and their effectiveness as treatments for ailments like tobacco addiction and PTSD. Of course, our conversation took as spin as we also touched on topics such as UFOs, DMT experiences and the CIA!

    Timestamps:

    0:00 – Intro
    1:10 – Dr. Johnson’s latest updates on treating smoking cessation with psilocybin
    6:55 – MAPS’ study using MDMA to treat PTSD
    7:20 – DMT’S mystical experiences of perceiving aliens, machine elves and autonomous beings
    13:08 – CIA research on psychedelics for telepathy and remote viewing
    15:01 – What is consciousness?
    19:02 – The intriguing evidence of UFOs?
    21:40 – Where do we see psychedelics going in the next 5 years?

    Make sure to like, share and subscribe if you enjoyed this episode!

    #Psychedelics #MatthewJohnson #UFO

  • MindMed Stock Price Targets [How HIGH can $MMED / $MMEDF Go?]🚀

    Today we are going to discuss my 5 year price targets for MindMed, MMEDF on the American OTC market, MMED on the Canadian Neo market and MMQ on the European Frankfurt Stock exchange.

    Piggy backing off of a decades worth of positive research showing that substances like LSD, Ibogaine, psilocybin and MDMA can treat mental health illnesses better than current methods by an order of magnitude, MindMed is in my opinion by far the most advanced psychedelic medicines company that retail investors can buy on the public markets which is why MindMedicine is one of my top psychedelic stocks in 2021.

    In this video, we’re going to look at 4 different 5 year price targets for MindMed, and assign them a level of probability. The four cases will be:
    1. The 5 year bear case for MindMed’s stock
    2. The Neutral case for MindMed LT
    3. The bull case price target for MindMed
    4. The Super Bull case

    Timestamps:
    0:00​ – Intro
    2:54 – The Bear Case for MindMed
    5:37 – The Neutral Case/ MindMed’s Stagnation
    7:49 – The Bull Case for MMED/MMEDF Stock
    10:18 – The Super Bull Case for MindMed
    13:08 – Note of Caution Plus Answer to Meor’s Nasdaq question

    Just as a brief note, in this video we are going to be using MMEDF, and all figures will be in American dollars

    And because this is all going to be speculation, the entirety of the episode will take place in, The Speculation Zone

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed​​​ ​#MindmedStock​​​ #MMEDNews